Search
for
Sort by
Research 241–270 of 1000+
- Medication Repurposing: New Uses for Old Drugs
- Urticaria, Drug Hypersensitivity Rashes, Nodules and Tumors, and Atrophic Diseases
- Sexual dimorphism of COVID-19 inspires drug repositioning and host-targeting immunotherapy for viral pneumonia
- Hair Loss in a Hemodialysis Patient after Repetitive Use of the Antipruritic Drug Nalfurafine: Implications of Impaired Angiogenesis for Hair Loss
- PATTERN OF CUTANEOUS MANIFESTATIONS OF DIABETES MELLITUS
- Alternative treatment of polycystic ovary syndrome: pre-clinical and clinical basis for using plant-based drugs
- The human gut chemical landscape predicts microbe-mediated biotransformation of foods and drugs
- Novel therapies for alopecia areata: The era of rational drug development
- Natural products and their derivatives as candidate treatments for hair greying: from drug discovery to molecular mechanisms
- The role of aquaporins in polycystic ovary syndrome – A way towards a novel drug target in PCOS
- Five year results of a prospective very low calorie diet or conventional weight loss programme in type 2 diabetes
- An assessment of curcumin, curcumin spanlastics nanoparticles, and curcumin nanocrystals as possible drug delivery systems with antimicrobial, antioxidant, and antitumor activities
- HANSRAJ (Adiantum capillus-veneris) -A REVIEW
- Westwood Carolina Conference on Clinical Dermatology
- Cardiovascular effects of hormone therapy for prostate cancer
- Charting the Bromodomain BRD4: Towards the Identification of Novel Inhibitors with Molecular Similarity and Receptor Mapping
- Assessment of Cardiovascular Risk and Prevention of Cardiovascular Disease in Women with the Polycystic Ovary Syndrome: A Consensus Statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society
- The Biological Actions of Dehydroepiandrosterone Involves Multiple Receptors
- Melatonin: functions and ligands
- INSULIN-LOWERING MEDICATIONS IN POLYCYSTIC OVARY SYNDROME
- Hair corticosterone measurement in mouse models of type 1 and type 2 diabetes mellitus
- Therapeutic options in the polycystic ovary syndrome
- Development of a new GC–MS/MS method for the determination of metformin in human hair
- Targets to treat androgen excess in polycystic ovary syndrome
- The Evaluation and Management of Hirsutism
- The Application of the Insulin to C-Peptide Molar Ratio (ICPR) in Primary Screening for Insulin Antibodies in Type 2 Diabetes Mellitus Patients: A Further Quantitative Study on the Relationship Between ICPR and Insulin Antibodies
- Diabetes mellitus and necrotizing fasciitis – a deadly combination; case report
- Hair Loss: A Harbinger of the Morbidities to Come!
- Treatment of hyperandrogenism in polycystic ovary syndrome
- Computational Drug Repositioning in Cardiorenal Disease: Opportunities, Challenges, and Approaches